Cargando…
Blind Spot: (18)F-FDG PET Fails to Reveal Atherosclerosis Aggravated by Cancer Immunotherapy
[Figure: see text]
Autores principales: | Ley, Klaus, Roy, Payel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352285/ https://www.ncbi.nlm.nih.gov/pubmed/34396272 http://dx.doi.org/10.1016/j.jaccao.2020.08.008 |
Ejemplares similares
-
TSH suppression aggravates arterial inflammation — an (18)F-FDG PET study in thyroid carcinoma patients
por: Boswijk, Ellen, et al.
Publicado: (2019) -
[(18)F]FDG PET/CT in the Evaluation of Melanoma Patients Treated with Immunotherapy
por: Mangas Losada, María, et al.
Publicado: (2023) -
(18)F-NaF and (18)F-FDG as molecular probes in the evaluation of atherosclerosis
por: McKenney-Drake, Mikaela L., et al.
Publicado: (2018) -
PET-Based Imaging with (18)F-FDG and (18)F-NaF to Assess Inflammation and Microcalcification in Atherosclerosis and Other Vascular and Thrombotic Disorders
por: Raynor, William Y., et al.
Publicado: (2021) -
PET probes beyond (18)F-FDG
por: Jiang, Lei, et al.
Publicado: (2014)